Boston Scientific Corp , which is in the midst of an attempted turnaround, reported weak sales of its heart stents and provided a disappointing fourth-quarter company sales forecast, sending its shares ...
via Business News - Yahoo Finance http://finance.yahoo.com/news/boston-scientific-stents-lag-cfo-195048185.html
via Business News - Yahoo Finance http://finance.yahoo.com/news/boston-scientific-stents-lag-cfo-195048185.html
0 commentaires:
Enregistrer un commentaire